Taken together, our research firstly explored the effect of fluoxetine on astrocytic GR level and location in corticosterone-induced depressive state, and suggested that fluoxetine modulated GR-TXNIP-GLUT1 pathway to improve astrocytic glucose uptake and glycolysis in corticosterone-induced depression. Here, NR3C1 is linked to depressive symptom measurement.